1. Budget projections and clinical impact of an immuno-oncology class of treatments: Experience in four EU markets. (June 2021) Authors: Rachev, Boris; Wilking, Nils; Kobelt, Gisela; Spandonaro, Federico; Rajer, Mirjana; Roediger, Alexander; Normand, Raphaël; Zielinski, Christoph Journal: Journal of cancer policy Issue: Volume 28(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PP39 Budget Projections And Health Impact Of PD-1/PD-L1 Inhibitors. (2019) Authors: Roediger, Alexander; van Bavel, Julie; Pellissier, James; Lucherini, Stefano; Davies, Neil; Okhuoya, Paul; Rachev, Boris Journal: International journal of technology assessment in health care Issue: Volume 35(2019)Supplement 1 Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Stakeholder point of view on prescription drug affordability - a systematic literature review and content analysis. Issue 9 (September 2021) Authors: Rachev, Boris; Uyei, Jennifer; Singh, Rajpal; Kowal, Stacey; Johnson, C. Erwin Journal: Health policy Issue: Volume 125:Issue 9(2021) Page Start: 1158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking. Issue 29 (23rd June 2022) Authors: Rodes-Sanchez, Marina; Spencer, Julia; Tantri, Anupama; Mitrovich, Rachel; Rachev, Boris; Sharma, Isha; Towse, Adrian; Steuten, Lotte Journal: Vaccine Issue: Volume 40:Issue 29(2022) Page Start: 3919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗